Last fall, when initial data from the Centers for Disease Control and Prevention showed a surprising drop in drug overdose deaths, the universal response was relief. We were finally getting ...

VIP36, a new CB1 agonist, targets a cryptic pocket to provide analgesia for chronic pain while minimizing side effects and avoiding opioid-related risks.